Animal Models of Peripheral Neuropathies

Research output: Contribution to journalArticle

Abstract

Peripheral neuropathies are common neurological diseases, and various animal models have been developed to study disease pathogenesis and test potential therapeutic drugs. Three commonly studied disease models with huge public health impact are diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and human immunodeficiency virus-associated sensory neuropathies. A common theme in these animal models is the comprehensive use of pathological, electrophysiological, and behavioral outcome measures that mimic the human disease. In recent years, the focus has shifted to the use of outcome measures that are also available in clinical use and can be done in a blinded and quantitative manner. One such evaluation tool is the evaluation of epidermal innervation with a simple skin biopsy. Future clinical trials will be needed to validate the translational usefulness of this outcome measure and validation against accepted outcome measures that rely on clinical symptoms or examination findings in patients.

Original languageEnglish (US)
Pages (from-to)262-269
Number of pages8
JournalNeurotherapeutics
Volume9
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Peripheral Nervous System Diseases
Animal Models
Outcome Assessment (Health Care)
Animal Disease Models
Diabetic Neuropathies
Public Health
Clinical Trials
HIV
Biopsy
Drug Therapy
Skin
Pharmaceutical Preparations
Therapeutics

Keywords

  • Chemotherapy
  • Diabetic autonomic neuropathy
  • Diabetic neuropathy
  • HIV-associated sensory neuropathy
  • Human immunodeficiency virus
  • Toxic neuropathy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Animal Models of Peripheral Neuropathies. / Hoke, Ahmet.

In: Neurotherapeutics, Vol. 9, No. 2, 04.2012, p. 262-269.

Research output: Contribution to journalArticle

Hoke, Ahmet. / Animal Models of Peripheral Neuropathies. In: Neurotherapeutics. 2012 ; Vol. 9, No. 2. pp. 262-269.
@article{7533f264600e40558270bb89c78e7e20,
title = "Animal Models of Peripheral Neuropathies",
abstract = "Peripheral neuropathies are common neurological diseases, and various animal models have been developed to study disease pathogenesis and test potential therapeutic drugs. Three commonly studied disease models with huge public health impact are diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and human immunodeficiency virus-associated sensory neuropathies. A common theme in these animal models is the comprehensive use of pathological, electrophysiological, and behavioral outcome measures that mimic the human disease. In recent years, the focus has shifted to the use of outcome measures that are also available in clinical use and can be done in a blinded and quantitative manner. One such evaluation tool is the evaluation of epidermal innervation with a simple skin biopsy. Future clinical trials will be needed to validate the translational usefulness of this outcome measure and validation against accepted outcome measures that rely on clinical symptoms or examination findings in patients.",
keywords = "Chemotherapy, Diabetic autonomic neuropathy, Diabetic neuropathy, HIV-associated sensory neuropathy, Human immunodeficiency virus, Toxic neuropathy",
author = "Ahmet Hoke",
year = "2012",
month = "4",
doi = "10.1007/s13311-012-0116-y",
language = "English (US)",
volume = "9",
pages = "262--269",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Animal Models of Peripheral Neuropathies

AU - Hoke, Ahmet

PY - 2012/4

Y1 - 2012/4

N2 - Peripheral neuropathies are common neurological diseases, and various animal models have been developed to study disease pathogenesis and test potential therapeutic drugs. Three commonly studied disease models with huge public health impact are diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and human immunodeficiency virus-associated sensory neuropathies. A common theme in these animal models is the comprehensive use of pathological, electrophysiological, and behavioral outcome measures that mimic the human disease. In recent years, the focus has shifted to the use of outcome measures that are also available in clinical use and can be done in a blinded and quantitative manner. One such evaluation tool is the evaluation of epidermal innervation with a simple skin biopsy. Future clinical trials will be needed to validate the translational usefulness of this outcome measure and validation against accepted outcome measures that rely on clinical symptoms or examination findings in patients.

AB - Peripheral neuropathies are common neurological diseases, and various animal models have been developed to study disease pathogenesis and test potential therapeutic drugs. Three commonly studied disease models with huge public health impact are diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and human immunodeficiency virus-associated sensory neuropathies. A common theme in these animal models is the comprehensive use of pathological, electrophysiological, and behavioral outcome measures that mimic the human disease. In recent years, the focus has shifted to the use of outcome measures that are also available in clinical use and can be done in a blinded and quantitative manner. One such evaluation tool is the evaluation of epidermal innervation with a simple skin biopsy. Future clinical trials will be needed to validate the translational usefulness of this outcome measure and validation against accepted outcome measures that rely on clinical symptoms or examination findings in patients.

KW - Chemotherapy

KW - Diabetic autonomic neuropathy

KW - Diabetic neuropathy

KW - HIV-associated sensory neuropathy

KW - Human immunodeficiency virus

KW - Toxic neuropathy

UR - http://www.scopus.com/inward/record.url?scp=84859721816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859721816&partnerID=8YFLogxK

U2 - 10.1007/s13311-012-0116-y

DO - 10.1007/s13311-012-0116-y

M3 - Article

C2 - 22415319

AN - SCOPUS:84859721816

VL - 9

SP - 262

EP - 269

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 2

ER -